• MANTRA

  Led · Equity · Aug 2025

  MANTRA aims to transform private-market assets into tradable digital tokens within the DeFi ecosystem, with real-time data reporting. The company is building a full market infrastructure for tokenized real-world assets (RWA) and plans to leverage regulatory frameworks and local infrastructure in the U.S. and the United Arab Emirates. MANTRA already has a Dubai subsidiary with a full license to operate digital-asset services. The recent strategic partnership with Inveniam and access to the AI capabilities of G42 in the UAE are positioned to accelerate that buildout. The initiative targets an estimated $18.9 trillion RWA opportunity by 2033. Operational metrics are under pressure: MANTRA’s TVL fell from over $4 million in April to under $500,000 in August while its native OM token collapsed more than 90%, erasing over $5 billion of market value. MANTRA Labs is an RWA L1 blockchain project focused on building compliant infrastructure for tokenizing real-world assets. The company provides developer support and tooling to accelerate RWA tokenization on its protocol. MANTRA’s stated goals include expanding RWA tokenization and creating an ecosystem that meets regulatory and compliance needs. The article reports MANTRA completed a financing of $11 million. The raise was described as a strategic investment led by Shorooq Partners. No operating metrics, founding year, or location were provided in the article.

• AtG Therapeutics

  Participated · Equity · Jul 2022

  AtG Therapeutics was launched to develop a portfolio of medicines for advanced cancers, initially focusing on therapies tied to a metabolic tumor target and a patient selector. The company will start with two programs: AtG 153, already in preclinical studies with animal models, and AngioDxPredict, which is in prototype development. Founders and senior team combine academic research expertise and industry experience to advance translational oncology assets. Initial indications targeted include renal, colorectal and breast cancers. The company intends to expand the initial portfolio into additional R&D programs for multiple oncologic indications. AtG emphasizes precision-medicine approaches to identify patients most likely to benefit from its treatments.

• Oasis Pro

  Participated · Series A · May 2022

  Oasis Pro’s subsidiary, Oasis Pro Markets, operates a U.S.-regulated multi-asset Alternative Trading System (OATSPRO) and a full-service investment banking practice for digital securities. OATSPRO supports fiat and digital-currency payments, KYC/AML onboarding, smart-contract-enabled real-time settlement, and a matching engine for primary issuance and secondary trading of public and private multi-asset digital securities. The platform targets real-estate related products including REITs and RMBS and positions itself as a liquidity venue for private and public OTC digital securities. Oasis Pro completed an oversubscribed $27+ million Series A financing to fund senior hires, expand global business development, scale its technology platform, and add complementary blockchain technologies. Proceeds will also accelerate Oasis Pro Markets’ Digital Asset Security ATS platform, global expansion, and its investment banking advisory practice; the company highlighted potential use cases such as Redwood Trust issuing mortgage-backed securities on the platform. The firm is based in Darien, Connecticut and is led by a team of Wall Street and blockchain veterans focused on bridging traditional finance and DeFi.

No current team members are available.